Company: AIBT
Filing Date: 2025-05-20
Form Type: 10-Q
Source: 0001096906-25-000861
Chunk: 3

Company: AIBOTICS, INC.
Filing Date: 2025-05-20
Form: 10-Q
Item: Item 1
Chunk 3
---
 value; 467,000,000 shares authorized at March 31, 2025 and December 31, 2024; 45,244,137 and 39,990,903 shares issued and outstanding as of March 31, 2025, and December 31, 2024, respectively

45,244

39,991

Additional paid in capital

7,518,238

7,374,297

Accumulated deficit

(11,400,653
)

(10,809,256
)

TOTAL STOCKHOLDERS’ DEFICIT

(3,836,971
)

(3,394,768
)

TOTAL LIABILITIES, MEZZANINE EQUITY AND STOCKHOLDERS’ DEFICIT
 
$
1,264,401

$
1,456,995

The accompanying notes are an integral part of these condensed consolidated financial statements.

4

AIBIOTICS THERAPIES, INC

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(Unaudited)